Viatris (VTRS) FCF Payout Ratio (2021 - 2026)
Viatris (VTRS) posted FCF Payout Ratio of 0.42 for Q2 2026, up 6.05% on a QoQ basis from 0.4 in Q1 2026, and down 49.3% year-over-year from 0.84 in Q2 2025.
Analysis
Viatris (VTRS) FCF Payout Ratio (2021 - 2026) Analysis & Trends
Viatris has reported FCF Payout Ratio for 6 years, with the latest figure at 0.42 in Q2 2026.
- On a quarterly basis, FCF Payout Ratio fell 49.3% year-over-year to 0.42 in Q2 2026; TTM through Jun 2026 was 0.29, a 12.3% decrease from a year earlier, with the FY2025 full-year figure at 0.29, changed 0.36% from the prior year.
- FCF Payout Ratio was 0.42 for Q2 2026 at Viatris, up from 0.4 in the prior quarter.
- The five-year high for FCF Payout Ratio was 4.12 in Q4 2022, with the low at 0.14 in Q1 2022.
- Average FCF Payout Ratio over 5 years is 0.52, with a median of 0.27 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: FCF Payout Ratio surged 909.38% in 2022, then tumbled 91.33% in 2023.
- Over 5 years, FCF Payout Ratio stood at 4.12 in 2022, then sank by 91.33% to 0.36 in 2023, then rose by 17.16% to 0.42 in 2024, then slumped by 46.7% to 0.22 in 2025, then soared by 90.42% to 0.42 in 2026.
- The last three FCF Payout Ratio figures came in at 0.42 (Q2 2026), 0.4 (Q1 2026), and 0.22 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | 0.42 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.42 |
| Mar 31, 2026 | 0.40 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | 0.19 |
| Jun 30, 2024 | 0.45 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | 0.19 |
| Jun 30, 2023 | 0.31 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 4.12 |
| Sep 30, 2022 | 0.19 |
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.14 |
| Dec 31, 2021 | 0.41 |
| Sep 30, 2021 | 0.14 |